385517000: Fondaparinux sodium (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Coagulation factor inhibitor\Coagulation factor Xa inhibitor\Fondaparinux sodium (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hematologic agent (substance)\...

\Blood derivative (substance)\Coagulation related substance (substance)\...

\Direct acting anticoagulant (substance)\Coagulation factor Xa inhibitor\Fondaparinux sodium (substance)

\Coagulation factor inhibitor\Coagulation factor Xa inhibitor\Fondaparinux sodium (substance)

\Anticoagulant (substance)\Direct acting anticoagulant (substance)\Coagulation factor Xa inhibitor\Fondaparinux sodium (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Carbohydrate\Complex carbohydrate\Oligosaccharide\Fondaparinux sodium (substance)

\Biological substance\Blood derivative (substance)\Coagulation related substance (substance)\Direct acting anticoagulant (substance)\Coagulation factor Xa inhibitor\Fondaparinux sodium (substance)
\Biological substance\Blood derivative (substance)\Coagulation related substance (substance)\Coagulation factor inhibitor\Coagulation factor Xa inhibitor\Fondaparinux sodium (substance)
\Biological substance\Nutrients\Carbohydrate\Complex carbohydrate\Oligosaccharide\Fondaparinux sodium (substance)
\Biological substance\Hemostasis related substance\Coagulation related substance (substance)\Direct acting anticoagulant (substance)\Coagulation factor Xa inhibitor\Fondaparinux sodium (substance)
\Biological substance\Hemostasis related substance\Coagulation related substance (substance)\Coagulation factor inhibitor\Coagulation factor Xa inhibitor\Fondaparinux sodium (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Fondaparinux sodium (substance)	Is a	Coagulation factor Xa inhibitor	true	Inferred relationship	Some
Fondaparinux sodium (substance)	Is a	Direct acting anticoagulant (substance)	false	Inferred relationship	Some
Fondaparinux sodium (substance)	Is a	Fondaparinux (substance)	false	Inferred relationship	Some
Fondaparinux sodium (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Coagulation factor Xa inhibitor	true	Inferred relationship	Some
Fondaparinux sodium (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Fondaparinux (substance)	true	Inferred relationship	Some
Fondaparinux sodium (substance)	Is a	Oligosaccharide	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fondaparinux sodium 5mg/mL injection solution 0.5mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fondaparinux sodium (substance)	Inferred relationship	Some
Product containing fondaparinux (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fondaparinux sodium (substance)	Inferred relationship	Some
Fondaparinux sodium 2.5mg/0.5mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fondaparinux sodium (substance)	Inferred relationship	Some
Fondaparinux sodium 2.5mg/0.5mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fondaparinux sodium (substance)	Inferred relationship	Some
Fondaparinux sodium 12.5mg/mL injection solution 0.4mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fondaparinux sodium (substance)	Inferred relationship	Some
Fondaparinux sodium 12.5mg/mL injection solution 0.6mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fondaparinux sodium (substance)	Inferred relationship	Some
Fondaparinux sodium 12.5mg/mL injection solution 0.8mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fondaparinux sodium (substance)	Inferred relationship	Some
Fondaparinux sodium 2.5mg/0.5mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fondaparinux sodium (substance)	Inferred relationship	Some
fondaparinux sodique	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fondaparinux sodium (substance)	Inferred relationship	Some
Product containing precisely fondaparinux sodium 5 milligram/0.4 milliliter conventional release solution for injection syringe	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Product containing precisely fondaparinux sodium 5 milligram/0.4 milliliter conventional release solution for injection syringe	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Product containing precisely fondaparinux sodium 7.5 milligram/0.6 milliliter conventional release solution for injection syringe	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Product containing precisely fondaparinux sodium 7.5 milligram/0.6 milliliter conventional release solution for injection syringe	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Product containing precisely fondaparinux sodium 2.5 milligram/0.5 milliliter conventional release solution for injection syringe	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Product containing precisely fondaparinux sodium 2.5 milligram/0.5 milliliter conventional release solution for injection syringe	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Product containing precisely fondaparinux sodium 10 milligram/0.8 milliliter conventional release solution for injection syringe	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Product containing precisely fondaparinux sodium 10 milligram/0.8 milliliter conventional release solution for injection syringe	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Product containing precisely fondaparinux sodium 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Product containing precisely fondaparinux sodium 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Fondaparinux sodium 5 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fondaparinux sodium (substance)	Inferred relationship	Some	1
Fondaparinux sodium 5 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fondaparinux sodium (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1459696014	Fondaparinux sodium (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1479722014	Fondaparinux sodium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
58381000195117	fondaparinux sodico	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
813161000172117	fondaparinux sodique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
234971000195117	Fondaparinuxnatrium	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
236731000195114	Fondaparinux-Natrium	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module